Miura backs Terrats Medical

Miura will partner with management on the transaction, which was structured as a buyout. The size of the stake secured by the PE house remains undisclosed.

The company had been family-owned for the past 70 years. The GP intends to boost its international expansion following the investment.

Miura is currently investing its third buyout vehicle, Miura Fund III, which held a final close on €330m in 2018. The fund has a focus on market leaders in specific niches based in Iberia, with sales in excess of €25m and EBITDA of more than €3m. In addition, Miura manages an agri-food-dedicated fund, Frutas, which closed on €360m in 2019.

Company
Terrats Medical designs and produces dental implants and abutments; it operates under the DESS brand. DESS is present in more than 35 countries and 90% of its revenues is generated through exports. Since 2009, the company has been focusing on a transformation from a specialist contract manufacturer of small metallic precision components to a global company in the dental implants market.

People
Miura Private Equity – Carlos Julià (partner).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Southern Europe
• Healthcare
• Buyouts
• Miura Private Equity
• Spain